|
| 36346687 | Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine. | Clin Cancer Res | 2023 |
| 37580913 | Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype. | Histopathology | 2023 |
| 37609778 | Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial. | Histopathology | 2023 |
| 37321155 | Harmonized molecular classification; assessment of a single-test ProMisE NGS tool. | Gynecol Oncol | 2023 |
| 37182372 | Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085]. | Mod Pathol | 2023 |
| 37339172 | The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas. | Clin Cancer Res | 2023 |
| 36753816 | Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer. | Gynecol Oncol | 2023 |
| 36788084 | Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death. | Mod Pathol | 2023 |
| 36731023 | Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol. | Int J Gynecol Pathol | 2023 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 35504673 | Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases. | Gynecol Oncol | 2022 |
| 36245879 | Psychoeducation, motivational interviewing, cognitive remediation training, and/or social skills training in combination for psychosocial functioning of patients with schizophrenia spectrum disorders: A systematic review and meta-analysis of randomized controlled trials. | Front Psychiatry | 2022 |
| 36100281 | Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma. | Int J Gynecol Cancer | 2022 |
| 35866380 | Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma. | J Pathol Clin Res | 2022 |
| 36031730 | The proteome of clear cell ovarian carcinoma. | J Pathol | 2022 |
| 35954471 | Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial. | Cancers (Basel) | 2022 |
| 35246332 | Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification. | Gynecol Oncol | 2022 |
| 32792599 | Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome. | Mod Pathol | 2021 |
| 33793971 | Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis. | Cancer | 2021 |
| 33570861 | Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant Performance. | Int J Gynecol Pathol | 2021 |
| 33709473 | Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer. | EMBO Mol Med | 2021 |
| 33804486 | Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints. | Cancers (Basel) | 2021 |
| 34863191 | From biobank and data silos into a data commons: convergence to support translational medicine. | J Transl Med | 2021 |
| 34612210 | International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings. | Int J Gynecol Pathol | 2021 |
| 34504086 | Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer. | NPJ Breast Cancer | 2021 |
| 34053140 | Reliability of Ki67 visual scoring app compared to eyeball estimate and digital image analysis and its prognostic significance in hormone receptor-positive breast cancer. | APMIS | 2021 |
| 34003287 | Response to Zhang and Yang. | J Natl Cancer Inst | 2021 |
| 34138519 | STING pathway expression in low-grade serous carcinoma of the ovary: an unexpected therapeutic opportunity? | J Pathol Clin Res | 2021 |
| 34026336 | The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine. | Oncoimmunology | 2021 |
| 33369635 | Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group. | J Natl Cancer Inst | 2021 |
| 33389409 | A clinical calculator to predict disease outcomes in women with triple-negative breast cancer. | Breast Cancer Res Treat | 2021 |
| 31094885 | Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction. | Int J Gynecol Pathol | 2020 |
| 31771962 | Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma. | Int J Gynecol Cancer | 2020 |
| 32686114 | Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours. | J Pathol | 2020 |
| 32685993 | Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer. | Breast Cancer Res Treat | 2020 |
| 32737030 | Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma. | Clin Cancer Res | 2020 |
| 32555365 | Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. | Br J Cancer | 2020 |
| 32360491 | Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinoma. | Hum Pathol | 2020 |
| 32473302 | Prognostic gene expression signature for high-grade serous ovarian cancer. | Ann Oncol | 2020 |
| 32414751 | FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes. | Clin Cancer Res | 2020 |
| 32521270 | Phospho-Ser<sup>784</sup>-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer. | Cell Rep | 2020 |
| 32409304 | Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type. | Clin Cancer Res | 2020 |
| 32564259 | Correction to: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort. | Breast Cancer Res Treat | 2020 |
| 32350416 | Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types. | Mod Pathol | 2020 |
| 31522348 | Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort. | Breast Cancer Res Treat | 2020 |
| 30326146 | Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome. | Histopathology | 2019 |
| 30181553 | Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study. | Lab Invest | 2019 |
| 30143750 | An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer. | Mod Pathol | 2019 |
| 31017314 | Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration. | Histopathology | 2019 |
| 30922603 | Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma. | Gynecol Oncol | 2019 |